Sculean A, Windisch P, Chiantella G C, Donos N, Brecx M, Reich E
Department of Periodontology and Conservative Dentistry, University of Saarland, Homburg, Germany.
J Clin Periodontol. 2001 May;28(5):397-403. doi: 10.1034/j.1600-051x.2001.028005397.x.
Utilisation of enamel matrix proteins (EMD) and application of the guided tissue regeneration principle (GTR) are treatment modalities which both have been shown to result in periodontal regeneration. However, it is yet unknown whether the combination of EMD and GTR may additionally favor the regeneration process.
The aim of the present controlled study was to evaluate clinically the treatment effect of EMD, GTR, combination of EMD and GTR, and flap surgery (control) on intrabony defects.
56 patients each of whom displaying one intrabony defect of a depth of at least 6 mm were randomly treated with one of the treatment modalities. Prior to surgery and at one year after, the following parameters were evaluated by a blinded examiner: Plaque index (PlI), gingival index (GI), bleeding on probing (BOP), probing pocket depth (PPD), gingival recession (GR) and clinical attachment level (CAL). No statistical significant differences between the four groups were observed at baseline for any of the investigated parameters.
At 1 year after therapy, the sites treated with EMD demonstrated a mean PPD reduction of 4.1 +/- 1.7 mm and a mean CAL gain of 3.4 +/- 1.5 mm (p<0.001). The sites treated with GTR showed a mean PPD reduction of 4.2 +/- 1.9 mm and a mean CAL gain of 3.1 +/- 1.5 mm (p<0.001). The sites treated with the combined treatment showed a mean PPD reduction of 4.3 +/- 1.4 mm and a mean CAL gain of 3.4 +/- 1.1 mm (p<0.001). In the control group, the mean PPD reduction was 3.7 +/- 1.4 mm (p<0.001) and the mean CAL gain measured 1.7 +/- 1.5 mm (p<0.01). All 4 treatments led to statistically significant PPD reduction and CAL gain. All three regenerative treatments led to higher CAL gain than the control treatment (p<0.05). No statistical significant differences in PPD reduction and CAL gain were observed between the three regenerative treatments.
It may be concluded that (a) all 3 regenerative treatment modalities may lead to higher CAL gain than the control one, and (b) the combined treatment does not seem to improve the outcome of the regenerative procedure.
牙釉质基质蛋白(EMD)的应用以及引导组织再生原理(GTR)的应用都是已被证明可导致牙周组织再生的治疗方式。然而,EMD与GTR联合使用是否能进一步促进再生过程尚不清楚。
本对照研究的目的是临床评估EMD、GTR、EMD与GTR联合应用以及翻瓣手术(对照)对骨内缺损的治疗效果。
56例患者,每人有一处深度至少为6mm的骨内缺损,随机接受上述一种治疗方式。在手术前及术后1年,由一名不知情的检查者评估以下参数:菌斑指数(PlI)、牙龈指数(GI)、探诊出血(BOP)、探诊深度(PPD)、牙龈退缩(GR)和临床附着水平(CAL)。在基线时,四组之间在所研究的任何参数上均未观察到统计学显著差异。
治疗后1年,接受EMD治疗的部位平均PPD减少4.1±1.7mm,平均CAL增加3.4±1.5mm(p<0.001)。接受GTR治疗的部位平均PPD减少4.2±1.9mm,平均CAL增加3.1±1.5mm(p<0.001)。接受联合治疗的部位平均PPD减少4.3±1.4mm,平均CAL增加3.4±1.1mm(p<0.001)。对照组平均PPD减少3.7±1.4mm(p<0.001),平均CAL增加1.7±1.5mm(p<0.01)。所有4种治疗均导致PPD显著减少和CAL增加。所有三种再生治疗导致的CAL增加均高于对照治疗(p<0.05)。三种再生治疗在PPD减少和CAL增加方面未观察到统计学显著差异。
可以得出结论:(a)所有三种再生治疗方式导致的CAL增加均高于对照治疗;(b)联合治疗似乎并未改善再生程序的结果。